Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Live Attenuated Zoster Vaccine in Adults Aged 40 Years or Older
NCT04334577Phase 3Completed
- Sponsor
- Changchun BCHT Biotechnology Co.
- Start
- Apr 2020
- Primary completion
- Jul 2021
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in herpes zoster (HZ) comparing Attenuated Zoster Vaccine, Live with Placebo (2 arms). Primary endpoint: The incidence of herpes zoster 30 days to 13 months after vaccination. Started Apr 2020; status: completed.
02
Drugs
zoster vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT04334577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04334577.